XBB.1.5 vaccine booster shows promise against new Omicron variants in latest study

A study posted to bioRxiv reveals that the monovalent XBB.1.5 vaccine booster significantly boosts neutralizing antibodies against new SARS-CoV-2 Omicron sub-variants. The research shows that both XBB.1.5 vaccination and infection elevate neutralizing titers, with the vaccine being particularly effective in infection-naïve individuals and those previously infected with Omicron.

Boehringer puts a target on Humira, says pushing it off formularies is necessary

For biosimilars to win, AbbVie has to lose, according to Boehringer Ingelheim. The German drugmaker on Wednesday said that its goal of getting more uptake

May 2, 2024

Looking past COPD, Regeneron CSO George Yancopoulos says Dupixent’s ‘next big thing’ is reversing allergies

SAN FRANCISCO — While Dupixent could add a major new indication in COPD this year, Regeneron’s longtime top scientist is already excited by the next

January 17, 2024

Open Blood-Brain Barrier for Alzheimer’s Treatment?; Managing TMD

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

January 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.